SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001420720-24-000015
Filing Date
2024-04-01
Accepted
2024-04-01 16:35:15
Documents
20
Period of Report
2024-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibio-20240326x8k.htm   iXBRL 8-K 51145
2 EX-4.1 ibio-20240326xex4d1.htm EX-4.1 123898
3 EX-4.2 ibio-20240326xex4d2.htm EX-4.2 125095
4 EX-10.1 ibio-20240326xex10d1.htm EX-10.1 353601
5 EX-10.2 ibio-20240326xex10d2.htm EX-10.2 63356
6 EX-10.3 ibio-20240326xex10d3.htm EX-10.3 52375
7 EX-99.1 ibio-20240326xex99d1.htm EX-99.1 12203
  Complete submission text file 0001420720-24-000015.txt   1053142

Data Files

Seq Description Document Type Size
8 EX-101.SCH ibio-20240326.xsd EX-101.SCH 4157
9 EX-101.DEF ibio-20240326_def.xml EX-101.DEF 3256
10 EX-101.LAB ibio-20240326_lab.xml EX-101.LAB 13973
11 EX-101.PRE ibio-20240326_pre.xml EX-101.PRE 10316
23 EXTRACTED XBRL INSTANCE DOCUMENT ibio-20240326x8k_htm.xml XML 4619
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 24810021
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)